Correlation Between Instil Bio and ABVC Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Instil Bio and ABVC Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Instil Bio and ABVC Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Instil Bio and ABVC Biopharma, you can compare the effects of market volatilities on Instil Bio and ABVC Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Instil Bio with a short position of ABVC Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Instil Bio and ABVC Biopharma.

Diversification Opportunities for Instil Bio and ABVC Biopharma

0.15
  Correlation Coefficient

Average diversification

The 3 months correlation between Instil and ABVC is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Instil Bio and ABVC Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ABVC Biopharma and Instil Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Instil Bio are associated (or correlated) with ABVC Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ABVC Biopharma has no effect on the direction of Instil Bio i.e., Instil Bio and ABVC Biopharma go up and down completely randomly.

Pair Corralation between Instil Bio and ABVC Biopharma

Considering the 90-day investment horizon Instil Bio is expected to generate 1.62 times more return on investment than ABVC Biopharma. However, Instil Bio is 1.62 times more volatile than ABVC Biopharma. It trades about -0.18 of its potential returns per unit of risk. ABVC Biopharma is currently generating about -0.35 per unit of risk. If you would invest  3,529  in Instil Bio on August 28, 2024 and sell it today you would lose (986.00) from holding Instil Bio or give up 27.94% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Instil Bio  vs.  ABVC Biopharma

 Performance 
       Timeline  
Instil Bio 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Instil Bio are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite quite unfluctuating forward indicators, Instil Bio disclosed solid returns over the last few months and may actually be approaching a breakup point.
ABVC Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ABVC Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Instil Bio and ABVC Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Instil Bio and ABVC Biopharma

The main advantage of trading using opposite Instil Bio and ABVC Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Instil Bio position performs unexpectedly, ABVC Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ABVC Biopharma will offset losses from the drop in ABVC Biopharma's long position.
The idea behind Instil Bio and ABVC Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals